Our mission is to uncover new chemical horizons and enable discovery of "improbable" small-molecule therapeutics, delivering immense value to patients in need.
With support from
DISCOVER THE PROBABLY IMPOSSIBLE
Our relentless quest to deliver to patients novel “unlikely” therapeutics is based on a combination of Deep Learning, Cloud Computing, and MoIDB(tm), our proprietary database of one trillion chemistries. This breakthrough technology supports our mission to improve the breadth and accuracy of pre-clinical drug discovery.
INNOVATE THROUGH ITERATION
Whether it’s a novel therapeutic target or a well studied one, our expert chemists and proprietary AI work together to identify the optimal small-molecule to support program goals. By combining human intuition with state of the art algorithms, we minimize the number of cycles needed to find the best drug for the task.